TY - JOUR AU - Staples, C. T. AU - Rimland, D. AU - Dudas, D. PY - 1999 DA - 1999// TI - Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival. JO - Clin Infect Dis VL - 29 UR - https://doi.org/10.1086/520144 DO - 10.1086/520144 ID - Staples1999 ER - TY - JOUR AU - Piroth, L. AU - Duong, M. AU - Quantin, C. PY - 1998 DA - 1998// TI - Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? JO - AIDS VL - 12 UR - https://doi.org/10.1097/00002030-199804000-00006 DO - 10.1097/00002030-199804000-00006 ID - Piroth1998 ER - TY - JOUR AU - Eyster, M. E. AU - Diamondstone, L. S. AU - Lien, J. M. AU - Ehmann, W. C. AU - Quan, S. AU - Goedert, J. J. PY - 1993 DA - 1993// TI - Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. JO - J Acquir Immune Defic Syndr VL - 6 ID - Eyster1993 ER - TY - JOUR AU - Martin, P. AU - Di, B. A. AU - Kassianides, C. AU - Lisker-Melman, M. AU - Hoofnagle, J. PY - 1989 DA - 1989// TI - Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. JO - Gastroenterology VL - 97 UR - https://doi.org/10.1016/0016-5085(89)90405-8 DO - 10.1016/0016-5085(89)90405-8 ID - Martin1989 ER - TY - JOUR AU - Benhamou, Y. AU - Di, M. V. AU - Bochet, M. PY - 2001 DA - 2001// TI - Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. JO - Hepatology VL - 34 UR - https://doi.org/10.1053/jhep.2001.26517 DO - 10.1053/jhep.2001.26517 ID - Benhamou2001 ER - TY - JOUR AU - Rockstroh, J. AU - Woitas, R. AU - Spengler, U. PY - 1998 DA - 1998// TI - Human immunodeficiency virus and hepatitis C virus coinfection. JO - Eur J Med Res VL - 3 ID - Rockstroh1998 ER - TY - JOUR AU - Sulkowski, M. S. AU - Mast, E. E. AU - Seeff, L. B. AU - Thomas, D. L. PY - 2000 DA - 2000// TI - Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. JO - Clin Infect Dis VL - 30 UR - https://doi.org/10.1086/313842 DO - 10.1086/313842 ID - Sulkowski2000 ER - TY - JOUR AU - Palella, F. AU - Delaney, K. AU - Moorman, A. PY - 1998 DA - 1998// TI - Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. JO - N Engl J Med VL - 338 UR - https://doi.org/10.1056/NEJM199803263381301 DO - 10.1056/NEJM199803263381301 ID - Palella1998 ER - TY - JOUR AU - Boyer, N. AU - Marcellin, P. AU - Degott, C. PY - 1992 DA - 1992// TI - Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comite des Anti-Viraux. JO - J Infect Dis VL - 165 UR - https://doi.org/10.1093/infdis/165.4.723 DO - 10.1093/infdis/165.4.723 ID - Boyer1992 ER - TY - JOUR AU - Marriott, E. AU - Navas, S. AU - del, R. J. PY - 1993 DA - 1993// TI - Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients. JO - J Med Virol VL - 40 UR - https://doi.org/10.1002/jmv.1890400206 DO - 10.1002/jmv.1890400206 ID - Marriott1993 ER - TY - JOUR AU - Soriano, V. AU - Garcia-Samaniego, J. AU - Bravo, R. PY - 1996 DA - 1996// TI - Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group. JO - Clin Infect Dis VL - 23 UR - https://doi.org/10.1093/clinids/23.3.585 DO - 10.1093/clinids/23.3.585 ID - Soriano1996 ER - TY - JOUR AU - McHutchison, J. AU - Gordon, S. AU - Schiff, E. PY - 1998 DA - 1998// TI - Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199811193392101 DO - 10.1056/NEJM199811193392101 ID - McHutchison1998 ER - TY - JOUR AU - Poynard, T. AU - Marcellin, P. AU - Lee, S. PY - 1998 DA - 1998// TI - Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)07124-4 DO - 10.1016/S0140-6736(98)07124-4 ID - Poynard1998 ER - TY - JOUR AU - Poynard, T. AU - McHutchison, J. AU - Davis, G. PY - 2000 DA - 2000// TI - Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. JO - Hepatology VL - 32 UR - https://doi.org/10.1053/jhep.2000.19347 DO - 10.1053/jhep.2000.19347 ID - Poynard2000 ER - TY - JOUR AU - Vogt, M. AU - Hartshorn, K. AU - Furman, P. PY - 1987 DA - 1987// TI - Ribavirin antagonizes the effect of azidothymidine on HIV replication. JO - Science VL - 235 UR - https://doi.org/10.1126/science.2435003 DO - 10.1126/science.2435003 ID - Vogt1987 ER - TY - JOUR AU - Lafeuillade, A. AU - Hittinger, G. AU - Chadapaud, S. PY - 2001 DA - 2001// TI - Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. JO - Lancet VL - 357 UR - https://doi.org/10.1016/S0140-6736(00)03618-7 DO - 10.1016/S0140-6736(00)03618-7 ID - Lafeuillade2001 ER - TY - JOUR AU - Sauleda, S. AU - Juarez, A. AU - Esteban, J. PY - 2001 DA - 2001// TI - Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders [In Process Citation]. JO - Hepatology VL - 34 UR - https://doi.org/10.1053/jhep.2001.29130 DO - 10.1053/jhep.2001.29130 ID - Sauleda2001 ER - TY - JOUR AU - Bruno MD, R. AU - Sacchi, P. AU - Maffezzini, E. AU - Zara, F. AU - Brunetti, E. AU - Filice, C. AU - Patruno, S. F. A. AU - Filice, G. PY - 1999 DA - 1999// TI - Daily Interferon regimen for chronic hepatitis C. A prospective randomized study. JO - Clin Drug Invest VL - 18 UR - https://doi.org/10.2165/00044011-199918010-00002 DO - 10.2165/00044011-199918010-00002 ID - Bruno MD1999 ER - TY - JOUR AU - Knodell, R. G. I. K. AU - Black, W. C. PY - 1981 DA - 1981// TI - Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. JO - Hepatology VL - 1 UR - https://doi.org/10.1002/hep.1840010511 DO - 10.1002/hep.1840010511 ID - Knodell1981 ER - TY - JOUR AU - Bonacini, M. AU - Puoti, M. PY - 2000 DA - 2000// TI - Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. JO - Arch Intern Med VL - 160 UR - https://doi.org/10.1001/archinte.160.22.3365 DO - 10.1001/archinte.160.22.3365 ID - Bonacini2000 ER - TY - JOUR AU - Prestileo, T. AU - Mazzola, G. AU - Di, L. F. PY - 2000 DA - 2000// TI - Response-adjusted alpha-interferon therapy for chronic hepatitis C in HIV-infected patients. JO - Int J Antimicrob Agents VL - 16 UR - https://doi.org/10.1016/S0924-8579(00)00259-4 DO - 10.1016/S0924-8579(00)00259-4 ID - Prestileo2000 ER - TY - JOUR AU - Bruno, R. AU - Sacchi, P. AU - Filice, C. AU - Filice, G. PY - 2000 DA - 2000// TI - Aggressive daily interferon therapy in HIV-HCV coinfected patients. JO - J Acquir Immune Defic Syndr VL - 25 UR - https://doi.org/10.1097/00126334-200012010-00014 DO - 10.1097/00126334-200012010-00014 ID - Bruno2000 ER - TY - JOUR AU - Hayashi, K. AU - Fukuda, Y. AU - Nakano, I. PY - 2000 DA - 2000// TI - Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus-infected haemophiliacs. JO - Haemophilia VL - 6 UR - https://doi.org/10.1046/j.1365-2516.2000.00444.x DO - 10.1046/j.1365-2516.2000.00444.x ID - Hayashi2000 ER - TY - JOUR AU - Landau, A. AU - Batisse, D. AU - Piketty, C. PY - 2001 DA - 2001// TI - Long-term efficacy of combination therapy with interferon-alpha2b and ribavirin for severe chronic hepatitis C in HIV-infected patients [In Process Citation]. JO - AIDS VL - 15 UR - https://doi.org/10.1097/00002030-200111090-00010 DO - 10.1097/00002030-200111090-00010 ID - Landau2001 ER - TY - JOUR AU - Nasti, G. AU - Di, G. G. AU - Tavio, M. PY - 2001 DA - 2001// TI - Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin. JO - AIDS VL - 15 UR - https://doi.org/10.1097/00002030-200109280-00006 DO - 10.1097/00002030-200109280-00006 ID - Nasti2001 ER - TY - JOUR AU - Kakuda, T. PY - 2000 DA - 2000// TI - Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. JO - Clin Ther VL - 22 UR - https://doi.org/10.1016/S0149-2918(00)90004-3 DO - 10.1016/S0149-2918(00)90004-3 ID - Kakuda2000 ER - TY - JOUR AU - White, A. PY - 2001 DA - 2001// TI - Mitochondrial toxicity and HIV therapy. JO - Sex Transm Inf VL - 77 UR - https://doi.org/10.1136/sti.77.3.158 DO - 10.1136/sti.77.3.158 ID - White2001 ER - TY - JOUR AU - Wiley, T. AU - Briedi, L. AU - Lam, N. AU - Layden, T. PY - 1998 DA - 1998// TI - Early HCV RNA values after interferon predict response. JO - Dig Dis Sci VL - 43 UR - https://doi.org/10.1023/A:1026613116942 DO - 10.1023/A:1026613116942 ID - Wiley1998 ER - TY - STD TI - Soriano VG-SJ, Perez-Olmeda M, Barreiro P, Nunez M, Rodriguez-Rosado R: Pegylated Interferon plus ribavirin for the treatment of chronic hepatitis C in HIV infected patients. 1st IAS Conference on HIV pathogenesis and treatment. Buenos Aires. July 8–11. 2001 ID - ref29 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/2/17/prepub UR - http://www.biomedcentral.com/1471-2334/2/17/prepub ID - ref30 ER -